LILRB1 and malaria: A subset of adaptive NK cells characterized by the lack of CD56 (NCAM1) and higher expression of inhibitory receptors LAG3 (CD223) and LILRB1 (CD85j) correlated with reduced parasitemia and protection against malaria symptoms in the subsequent year [27].